Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue ...

Vertex Pharmaceuticals has significantly underperformed the broader market over the past year, yet analysts remain optimistic ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As 85% of consumers begin summer shopping in late winter, businesses face a new peak season – and a growing need for ...

Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage ...

The heritage British brand has been revived by a chairman whose impressive career before watchmaking includes a three-year ...

Shares of Vertex Pharmaceuticals sank 15% after the drugmaker announced a study showed its experimental pain medicine was not ...

Credit on UPI fintech Kiwi has raised ₹208 Crore ($24 million) in its Series B funding round, led by Vertex Ventures South ...

Vertex Pharmaceuticals' Seaport headquarters buildings have been refinanced for $1 billion, putting a ten-figure value on an ...